Nicholas Investment Partners’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-200,000
| Closed | -$2.05M | – | 214 |
|
|
2023
Q2 | $2.05M | Hold |
200,000
| – | – | 0.14% | 136 |
|
|
2023
Q1 | $2.02M | Hold |
200,000
| – | – | 0.15% | 128 |
|
|
2022
Q4 | $1.98M | Hold |
200,000
| – | – | 0.17% | 122 |
|
|
2022
Q3 | $1.94M | Hold |
200,000
| – | – | 0.18% | 124 |
|
|
2022
Q2 | $1.94M | Hold |
200,000
| – | – | 0.18% | 128 |
|
|
2022
Q1 | $1.95M | Hold |
200,000
| – | – | 0.14% | 149 |
|
|
2021
Q4 | $1.96M | Hold |
200,000
| – | – | 0.12% | 160 |
|
|
2021
Q3 | $1.97M | Buy |
+200,000
| New | +$1.97M | 0.14% | 152 |
|